Original investigation
A review of therapeutic studies of idiopathic membranous glomerulopathy,☆☆

https://doi.org/10.1016/0272-6386(95)90568-5Get rights and content

Abstract

The treatment of idiopathic membranous glomerulopathy remains an enigma. We have reviewed many of the important clinical trials concerning membranous glomerulopathy using a meta-analysis and a secondary pooled analysis to test the effects of corticosteroid or alkylating therapy compared with no treatment on renal survival and complete remission of the nephrotic syndrome. A search was performed using MEDLINE (1968 through 1993) for articles on idiopathic membranous glomerulopathy and glomerulonephritis. Bibliographies of articles were reviewed for completeness. Sixty-nine articles were reviewed. Meta-analysis was performed for four trials that evaluated corticosteroids compared with no treatment and for three trials that evaluated alkylating therapy compared with no treatment. Pooled analysis was performed on randomized and prospective studies (10 studies) and then with 22 case series added. All studies evaluated renal biopsy-proven disease. Meta-analysis was performed on the relative chance of being in complete remission for each study. Renal survival could be evaluated by pooled analysis only. For pooled analyses, Cox's proportional hazard and logistic regression models were used to test the effect of therapy on renal survival and the nephrotic syndrome, respectively. Data concerning gender, nephrotic syndrome, and geographic region were used in all statistical models. Evaluation of renal survival revealed no differences by treatment group (P > 0.1). By meta-analysis, the relative chance of complete remission was not improved for corticosteroid-treated patients (1.55; 95% confidence interval, 0.99 to 2.44; P > 0.1), but was improved for patients treated with alkylating agents (4.8; 95% confidence interval, 1.44 to 15.96; P < 0.05) when compared with no treatment. Pooled analysis of randomized and prospective studies, as well pooled analysis with all studies, supported the findings of the meta-analysis. Corticosteroids or alkylating therapy did not improve renal survival in idiopathic membranous glomerulopathy. Complete remission of the nephrotic syndrome was observed more frequently with the use of alkylating agents.

References (96)

  • JV Donadio et al.

    Idiopathic membranous nephropathy: The natural history of untreated patients

    Kidney Int

    (1988)
  • E Alexopoulos et al.

    Cyclophosphamide provides no additional benefit to steroid therapy in the treatment of idiopathic membranous nephropathy

    Am J Kidney Dis

    (1993)
  • WK Bolton et al.

    Therapy of the idiopathic nephrotic syndrome with alternate day steroids

    Am J Med

    (1977)
  • ML West et al.

    A controlled trial of cyclophosphamide in patients with membranous glomerulonephritis

    Kidney Int

    (1987)
  • G Warwick et al.

    Immunosuppression for membranous nephropathy

    Lancet

    (1988)
  • PW Mathieson et al.

    Prednisolone and chlorambucil treatment in idiopathic membranous nephropathy with deteriorating renal function

    Lancet

    (1988)
  • K Jindal et al.

    Long-term benefits of therapy with cyclophosphamide and prednisone in patients with membranous glomerulonephritis and impaired renal function

    Am J Kidney Dis

    (1992)
  • DM Thomas et al.

    Enalapril can treat the proteinuria of membranous glomerulonephritis without detriment to systemic or renal hemodynamics

    Am J Kidney Dis

    (1991)
  • R Habib et al.

    Extramembranous glomerulonephritis in children: Report of 50 cases

    J Pediatr

    (1973)
  • K Dickersin et al.

    Identification of meta-analyses: The need for standard terminology

    Controlled Clin Trials

    (1990)
  • SJ Pocock

    The combination of randomized and historical controls in clinical trials

    J Chronic Dis

    (1976)
  • AM Pierides et al.

    Idiopathic membranous nephropathy

    Nephron

    (1978)
  • JS Cameron

    Membranous nephropathy: The treatment dilemma

    Am J Kidney Dis

    (1982)
  • R D'Achiardi-Rey et al.

    Membranous glomerulonephropathy: There is no significant effect of treatment with corticosteroids

    Am J Kidney Dis

    (1982)
  • AS Relman

    What have we learned about the treatment of idiopathic membranous nephropathy with steroids?

    N Engl J Med

    (1989)
  • HA Austin et al.

    Membranous nephropathy

    Ann Intern Med

    (1992)
  • JS Cameron

    Membranous nephropathy—Still a treatment dilemma

    N Engl J Med

    (1992)
  • EJ Lewis

    Idiopathic membranous nephropathy—To treat or not to treat?

    N Engl J Med

    (1993)
  • C Ponticelli et al.

    Remissions and relapses in idiopathic membranous nephropathy

    Nephrol Dial Transplant

    (1992)
  • T Ehrenreich et al.

    Pathology of membranous nephropathy

  • VE Pollak et al.

    Natural history of lipoid nephrosis and of membranous glomerulonephritis

    Ann Intern Med

    (1968)
  • RM McIntosh et al.

    Immunohistology in renal disease

    Q J Med

    (1971)
  • PG Row et al.

    Membranous nephropathy

  • JS Cameron et al.

    The Medical Research Council trial of short-term high-dose alternate day prednisolone in idiopathic membranous nephropathy with nephrotic syndrome in adults

    Q J Med

    (1990)
  • DC Cattran et al.

    A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy

    N Engl J Med

    (1989)
  • Y Kobayashi et al.

    Prednisone treatment in non nephrotic patients with idiopathic membranous nephropathy

  • C Ponticelli et al.

    A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy

    N Engl J Med

    (1989)
  • BF Murphy et al.

    Randomized controlled trial of cyclophosphamide, warfarin and dipyridamole in idiopathic membranous glomerulonephritis

    Clin Nephrol

    (1992)
  • C Ponticelli et al.

    Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy

    N Engl J Med

    (1992)
  • Medical Research Council Working Party

    controlled trial of azathioprine and prednisone in chronic renal disease

    BMJ

    (1971)
  • Controlled trial of azathioprine in the nephrotic syndrome secondary to idiopathic membranous glomerulonephritis

    Can Med Assoc J

    (1976)
  • M Forland et al.

    Clinicopathological correlations in idiopathic nephrotic syndrome with membranous nephropathy

    Nephron

    (1969)
  • DT Erwin et al.

    The clinical course of idiopathic membranous nephropathy

    Mayo Clinic Proc

    (1973)
  • JP Hayslett et al.

    Clinicopathological correlations in the nephrotic syndrome due to primary renal disease

    Medicine

    (1973)
  • AM Pierides et al.

    Idiopathic membranous nephropathy

    Q J Med

    (1977)
  • J Hopper et al.

    Membranous nephropathy: Its relative benignity in women

    Nephron

    (1981)
  • E Honkanen

    Survival in idiopathic membranous glomerulonephritis

    Clin Nephrol

    (1986)
  • Cited by (185)

    • Cytokines network in primary membranous nephropathy

      2022, International Immunopharmacology
      Citation Excerpt :

      However, the efficacy of glucocorticoids alone in PMN therapy is not positive, particularly when oral treatment does not show long-term benefit [111–113]. Nevertheless, in some secondary membranous nephropathy, glucocorticoid therapy alone is effective [113,114]. So the key question is whether the autoimmune response to podocyte antigens is activated.

    • Sex and Gender in Glomerular Disease

      2022, Seminars in Nephrology
    View all citing articles on Scopus

    Supported in part by a grant from the REN Corporation, Nashville, TN.

    ☆☆

    Presented in part at the 26th annual American Society of Nephrology meeting, November 1993, and published in abstract form in the Journal of the American Society of Nephrology (4:277, 1993).

    View full text